Rchr
J-GLOBAL ID:201801014098350160   Update date: May. 23, 2024

Itokawa Norio

Itokawa Norio
Affiliation and department:
Research field  (1): Gastroenterology
Research keywords  (1): 肝疾患
Papers (233):
  • Masanori Inoue, Sadahisa Ogasawara, Kazufumi Kobayashi, Tomomi Okubo, Norio Itokawa, Masamichi Obu, Kentaro Fujimoto, Hidemi Unozawa, Sae Yumita, Kisako Fujiwara, et al. Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy. Liver Cancer. 2024
  • Kazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta, Tomomi Okubo, Norio Itokawa, Yuki Haga, Yuya Seko, Michihisa Moriguchi, Shunji Watanabe, Yuki Shiko, et al. A prospective study exploring the safety and efficacy of lenvatinib for patients with advanced hepatocellular carcinoma and high tumor burden: The LAUNCH study. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023
  • Seiji Futagami, Shuhei Agawa, Ken Nakamura, Yoshiyuki Watanabe, Mayu Habiro, Rie Kawawa, Hiroshi Yamawaki, Rina Tsushima, Kumiko Kirita, Teppei Akimoto, et al. Apolipoprotein A2 isoforms associated with exocrine pancreatic insufficiency in early chronic pancreatitis. Journal of gastroenterology and hepatology. 2023
  • Masanori Atsukawa, Akihito Tsubota, Yuichi Tamura, Kaori Koyano-Shioda, Tadamichi Kawano, Tomomi Okubo, Korenobu Hayama, Taeang Arai, Norio Itokawa, Yu Taniguchi, et al. How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis. JGH Open. 2023
  • Hiroaki Kanzaki, Sadahisa Ogasawara, Tomomi Okubo, Norio Itokawa, Ryohei Yoshino, Kentaro Fujimoto, Tadayoshi Kogure, Sae Yumita, Takamasa Ishino, Keita Ogawa, et al. Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis. Drugs - real world outcomes. 2023
more...
MISC (94):
  • 中川美由貴, 小笠原定久, 大部誠道, 大久保知美, 糸川典夫, 駒嘉宏, 畦元亮作, 厚川正則, 糸林詠, 加藤直也. 進行肝細胞癌と他癌腫における免疫チェックポイント阻害薬投与中に出現したAST/ALT上昇の鑑別の重要性. 日本内科学会雑誌. 2023. 112
  • 大野弘貴, 河野惟道, 新井泰央, 吉田祐士, 大久保知美, 葉山惟信, 糸川典夫, 厚川正則, 岩切勝彦. 高脂血症合併NAFLD患者に対するペマフィブラートの肝病態に与える影響の検討. 日本消化器病学会雑誌(Web). 2022. 119
  • 中村拳, 葉山惟信, 糸川典夫, 塩田香織, 大野弘貴, 河野惟道, 吉田祐士, 田邉智英, 大久保知美, 新井泰央, et al. 切除不能肝細胞癌に対するアテゾリツマブ+ベバシズマブ併用療法の初期治療経験. 日本消化器病学会雑誌(Web). 2022. 119
  • 吉田祐士, 厚川正則, 塩田香織, 大野弘貴, 河野惟道, 田邊智英, 大久保知美, 葉山惟信, 金子恵子, 新井泰央, et al. C型肝炎患者におけるDAA治療後のSVR後肝発癌を予測するnew formulaの有用性. 日本消化器病学会雑誌(Web). 2022. 119
  • 新井泰央, 厚川正則, 長谷川雄太, 大野弘貴, 河野惟道, 吉田祐士, 大久保知美, 岩下愛, 葉山惟信, 糸川典夫, et al. 2型糖尿病合併NAFLD患者における経口セマグルチドの肝病態改善効果の検証. 肝臓. 2022. 63. Supplement 1
more...
Education (1):
  • - 2006 Nippon Medical School Medical School
Professional career (1):
  • 医学博士
Work history (5):
  • 2020/10 - 現在 日本医科大学付属病院 消化器肝臓内科 講師
  • 2020/04 - 2020/09 日本医科大学付属病院 消化器肝臓内科 病院講師
  • 2017/10 - 2020/03 Nippon Medical School
  • 2012/04 - 2017/09 Nippon Medical School
  • 2010/04 - 2012/03 Nippon Medical School
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page